Filing Details
- Accession Number:
- 0001209191-23-021743
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-30 21:04:35
- Reporting Period:
- 2023-03-28
- Accepted Time:
- 2023-03-30 21:04:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1607678 | Viking Therapeutics Inc. | VKTX | Pharmaceutical Preparations (2834) | 461073877 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838112 | Marianna Mancini | C/O Viking Therapeutics, Inc. 9920 Pacific Heights Blvd, Suite 350 San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 15,000 | $2.15 | 332,273 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 4,873 | $1.88 | 337,146 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 15,000 | $1.26 | 352,146 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 53,054 | $1.23 | 405,200 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 15,000 | $1.08 | 420,200 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 10,000 | $1.04 | 430,200 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 24,500 | $4.65 | 454,700 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-28 | 30,000 | $4.37 | 484,700 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2023-03-28 | 196,563 | $15.00 | 288,137 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2023-03-29 | 15,000 | $9.13 | 303,137 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2023-03-29 | 41,242 | $16.00 | 261,895 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 15,000 | $0.00 | 15,000 | $2.15 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 4,873 | $0.00 | 4,873 | $1.88 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 15,000 | $0.00 | 15,000 | $1.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 53,054 | $0.00 | 53,054 | $1.23 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 15,000 | $0.00 | 15,000 | $1.08 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 10,000 | $0.00 | 10,000 | $1.04 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 24,500 | $0.00 | 24,500 | $4.65 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-28 | 30,000 | $0.00 | 30,000 | $4.37 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-29 | 15,000 | $0.00 | 15,000 | $9.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-04 | 2026-03-04 | No | 4 | M | Direct |
| 0 | 2016-03-14 | 2026-03-14 | No | 4 | M | Direct |
| 0 | 2017-06-30 | 2026-06-30 | No | 4 | M | Direct |
| 0 | 2017-01-05 | 2027-01-05 | No | 4 | M | Direct |
| 0 | 2018-06-30 | 2027-06-30 | No | 4 | M | Direct |
| 0 | 2018-08-31 | 2027-08-31 | No | 4 | M | Direct |
| 0 | 2019-01-19 | 2028-01-19 | No | 4 | M | Direct |
| 0 | 2019-03-30 | 2028-03-30 | No | 4 | M | Direct |
| 0 | 2016-05-21 | 2025-05-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
- 25% of the shares subject to the option vested on each one year anniversary of the grant date.
- The shares subject to the option vested on the grant date.
- 23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date.
- One-third of the shares subject to the option vested on each one year anniversary of the grant date.
Billionaire Hedge Funds
